Peripheral neuropathy, a result of damage to the nerves outside the brain and spinal cord, often causes weakness, numbness, and pain, typically in the hands and feet. It can also affect other areas of the body. This article aims to provide healthcare professionals with a comprehensive understanding of peripheral neuropathy evaluation.
Peripheral neuropathy can result from traumatic injuries, infections, metabolic problems, inherited causes, and exposure to toxins. One of the most common causes is diabetes. Symptoms can range from temporary numbness, tingling, and pricking sensations, to more severe complications such as muscle weakness or difficulty moving.
Early diagnosis and treatment offer the best chance for controlling symptoms and preventing further damage to peripheral nerves. The primary diagnostic tools are physical examination and patient history. Neurological examinations can reveal signs of nerve damage such as decreased reflexes, weakness, and sensory deficits. Additional tests may include Electromyography (EMG), Nerve conduction velocity (NCV) test, and blood tests.
Treatment goals are to manage the condition causing the neuropathy and to relieve symptoms. If diabetes is the cause, controlling blood sugar levels may help prevent further nerve damage. For other causes, treatment options might include medications, physical therapy, or surgical interventions. Pain management is also an important part of treatment.
Peripheral neuropathy is a complex condition with a wide range of potential causes and symptoms. A thorough understanding of its evaluation process is crucial for healthcare professionals to provide effective treatment and management. With early diagnosis and appropriate intervention, the progression of peripheral neuropathy can be slowed, and patients' quality of life can be significantly improved.
1.
Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.
2.
Childhood cancer survivors face new health problems later in life, study shows
3.
Genomic Newborn Screening Could Identify Childhood Cancer Predisposition
4.
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
5.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
1.
Obesity is a major risk factor for cancer
2.
Prevention of Thrombotic Complications in High-Risk Patients
3.
Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy
4.
Megakaryocyte Immune Cell Crosstalk: Mechanisms, Clinical Insights, and Therapeutic Implications
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Hands-on Workshop: Hematology
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
5.
Immunotherapy: A New Era in Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation